fluorouracil and jte 013

fluorouracil has been researched along with jte 013 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Cui, S; Guo, Z; Han, G; Liu, S; Liu, X; Luo, D; Lv, Y; Qu, X; Tian, X; Wan, S; Wang, W; Yang, S; Zhang, Y1
Luo, DD; Qu, XJ; Wan, SB; Zhang, YH1

Other Studies

2 other study(ies) available for fluorouracil and jte 013

ArticleYear
Design, synthesis and biological evaluation of sphingosine-1-phosphate receptor 2 antagonists as potent 5-FU-resistance reversal agents for the treatment of colorectal cancer.
    European journal of medicinal chemistry, 2021, Dec-05, Volume: 225

    Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Cells, Cultured; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Molecular Structure; Sphingosine-1-Phosphate Receptors; Structure-Activity Relationship

2021
S1PR2 inhibitors potently reverse 5-FU resistance by downregulating DPD expression in colorectal cancer.
    Pharmacological research, 2020, Volume: 155

    Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Colorectal Neoplasms; Dihydrouracil Dehydrogenase (NADP); Down-Regulation; Drug Resistance, Neoplasm; Fluorouracil; Humans; Mice, Nude; Molecular Docking Simulation; Pyrazoles; Pyridines; Sphingosine-1-Phosphate Receptors

2020